Articles On Mach7 Technologies (ASX:M7T)

ASX health sector falls 2.2% for the week as rotation back to sector loses momentum, while broader market up 0.2%  Cochlear backed Epiminder has a disappointing first week on the ASX after its IPO on Monday Mach7 signs a five-year subscrip...

ASX healthcare sector gains 1.99% in November while benchmark ASX 200 down 2.66% Mach7 rises 50% in November with health imaging stock outlining a growth strategy at its AGM  Island Pharmaceuticals rises after FDA confirms Galidesivir will...

The team at Morgans has been busy running the rule over a number of popular ASX shares in recent days. Let's see what the broker is saying about them and whether it thinks they are in the buy zone right now: A2 Milk Company Ltd (ASX: A2M)...

ASX health sector down 0.94% for past week, while broader market falls 1.22% Under pressure CSL moves to reassure investors at US Capital Markets Day this week Imricor soars after world’s first VT ablation performed entirely under real-tim...

Mach7 Technologies (ASX:M7T) shareholders, customers and staff should know what to expect from new CEO Teri Thomas, who is adopting a similar playbook to the one to which everyone sang along at breast imaging house Volpara Health Technologi...

MoneyTalks is Stockhead’s drill down into what stocks investors are looking at right now. We tap our list of experts to hear what’s hot, their top picks and what they’re looking out for. In this edition we hear from senior healthcare analys...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena's Monitor keeps track of corporate earnings result releases, including broke...

Chemist giant Sigma is posting double-digit sales growth … … whilst rival EBOS meets guidance Mach 7 puts customers first in ‘back to basics’ approach   A little over six months after merging with Chemist Warehouse (CW), Sigma Healthcare...

ASX heath sector falls 0.65 % in past five days but returns 9% in July in a strong comeback  ‘Mostly pretty good’ June quarterly reporting season comes to end  Clarity Pharmaceuticals completes $203 million capital raise to institutional i...

ASX health stocks rally 5.4% over five days as Morgans’ Scott Power says optimism is returning to the sector The sector’s largest stock CSL is up 10% over past two weeks with other key plays also showing momentum  With new CEO Terri Thomas...

ASX health stocks fall o.92% over past five days as US President Donald Trump renews tariff threat on pharmaceutical imports Morgans believes ASX’s biggest biotech CSL  is currently trading at levels significantly below fair value Cochlear...

The S&P/ASX 200 Index (ASX: XJO) is on course to end the week in the red. In afternoon trade, the benchmark index is down 0.3% to 8,500.9 points. Four ASX shares that are not letting that hold them back are listed below. Here's why they...

ASX heath sector falls 1.3%, trailing ASX 200 up 1.1% as macro picture remains uncertain but ‘little bit better’ Soft-tissue repair company Aroa Biosurgery reconfirms FY25 reported revenue guidance of NZ$81-84 million Medical imaging softe...

The big-name biotechs present short-term trading opportunities for bold investors Nothing to see here, says Sigma Healthcare Broker reckons Mach 7 shares should be worth four times more than their current value   The topsy-turvy market ha...

Certain ASX-listed medtech companies are delivering technologies that enhance clinical precision, safety and efficiency in healthcare For example, Imricor is pioneering cardiac ablations using MRI instead of traditional x-ray fluoroscopy t...

Some investors contend Clinuvel’s mountain of $200 million of cash is excessive and amounts to a ‘lazy’ balance sheet The company argues the cash buffer protects it against unexpected adversities and – in any event – every cent will be nee...

The winds of CEO change bloweth through the early commercial-stage end of the market Trial news from Neurizon and Blinklab Opthea’s latest setback brings perversely good news   The long-standing CEOs of two early commercial stage biotech...

Morgans analyst Scott Power said this ‘particular reporting season has been one of the worst for a long time’ for ASX healthcare sector ‘Chronic underperformer’ Ramsay Health Care reporting strong performance in its Aussie and UK hospitals...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today’s Reports: ((ACF)) – Acrow...

Middle East healthcare sector undergoing rapid expansion presenting opportunities for ASX-listed companies ImpediMed has a distributor in Qatar for its SOZO bioimpedance spectroscopy (BIS) device for early detection and prevention of lymph...

Highlights: Fisher & Paykel Healthcare (ASX:FPH) faces new tariffs but is adapting with strategic measures. Orthocell (ASX:OCC) is progressing with regulatory approvals in multiple markets. Life-sciences...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another gain. At the time of writing, the benchmark index is up 0.35% to 8,476.2 points. Four ASX shares that are rising more than most today are listed below....

My pick for a great share to buy in 2025 is ASX penny stock Mach7 Technologies Ltd (ASX: M7T). Wait, wait – before you stop reading, hear me out! Sure, the company's share price is down over 50% this year. And yes, the company poste...

Several ASX healthcare companies have upcoming catalysts, which can be a focal point for healthcare investors Dimerix forecasts the second interim analysis of its ACTION 3 global phase III trial of DMX-200 to treat FSGS in around mid-CY25...

Do you have a high tolerance for risk? If you do, you might want to check out the small cap ASX shares named below that brokers are tipping as buys with potential for massive returns. Let's see what they are saying about these stocks: Camp...

ASX medical imaging companies are capitalising on lucrative market of caring for US veterans with their innovative technologies Mach7  selected as solution provider for Veterans Health Administration National Teleradiology Program  SHG sec...

World Health Organsiation projects a shortfall of 10 million health workers by 2030 HeraMED’s platform helps healthcare providers manage maternity patients remotely Optiscan platform could address shortage of pathologists in Australia and...

 The little-known PharmX facilitates $20 billion of transactions between chemists and their suppliers annually  Mesoblast is one of the most closely watched of  today’s crop of last-minute quarterly reporters  Pro Medicus ‘mini- me’ Mach 7...

Investors with a higher tolerance for risk might want to check out the small cap ASX shares listed below that brokers are tipping as buys. Let's see what they are saying about these stocks: Aeris Resources Ltd (ASX: AIS) Bell Potter thinks...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today’s Reports: ((AIS)) – Aeris...

ASX health stocks dropped 1.22% in the past four days, while the broader markets fell 1.35% Morgans downgrades Ramsay Health Care following its FY24 results, believes a ‘near-term earnings recovery looks challenging’ Percheron reports posi...

The share price of ASX penny stock Mach7 Technologies Ltd (ASX: M7T) has plunged more than 30% in the past year. Shares of the ASX health tech company closed on Friday at a new 52-week low of just 53 cents apiece. Long-term investors wil...

ASX health stocks flat for week in line while broader markets rise of 0.5% Nanosonics has risen ~17% in the past five days on its FY24 result Mach7 falls falls as investing in growth plans push out profit expectations    Healthcare and li...

The share price of Mach7 Technologies Ltd (ASX: M7T), a medical imaging systems provider, is down 4.2% today after the ASX healthcare company reported its FY24 results. Mach7 Technologies shares have not performed well over the past year...

ASX to open lower despite the Dow Jones hitting a new high Nvidia’s earnings report will be the major event later tonight Apple’s stock rose with the appointment of a new CFO   The ASX is expected to open lower on Wednesday despite the Do...

ASX health stocks rise at time of publishing, in line with broader markets amid mixed reporting season EBOS FY24 result in line with consensus as it looks to fill hole by loss of Chemist Warehouse contract Healius says pathology needs more...

ASX health stocks rise 0.9% in past five days as broader markets lift 1.2%, despite Friday selloff ImpediMed’s latest quarterly result shows sales momentum building for Sozo device  Cold-cathode X-ray machine developer MicroX makes progres...

Biotron jumps after Phase 2 trial success Biotron (ASX:BIT) jumped +15% this morning after announcing promising results from its BIT225-011 Phase 2 clinical trial, indicating that the primary objectives of the study have been achieved. This...

MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts to hear what’s hot, their top picks, and what they’re looking out for. Today we hear from Merewether C...

ASX health stock rise  in past five days along with broader markets  Wound care company Polynovo achieves its first ever $10m+ revenue month in April Power says Neuren selloff a “complete overreaction” after US partner Arcadia’s latest res...

Several ASX medtech companies have upcoming catalysts in 2024 as they look to transform healthcare  Imricor preparing to treat its first ventricular tachycardia patient this quarter  Optiscan on schedule for launch of breast surgical devic...

If you have a higher than average tolerance for risk, then you might want to consider adding some small cap exposure to your portfolio. But which small cap ASX shares should you buy? Listed below are three that Morgans rates very highly. He...

Small-cap shares suffered greatly during the period of 13 interest rate rises over 2022 and 2023. But with inflation cooling and the prospect of rate cuts coming, the little guys are starting to play catch up to the medium and large caps....

ASX health sector rises in line with broader markets in the past five days  AdAlta reports positive Phase 1 extension trial results of AD-214 into IPF Mach7 signs $3.1 million, three-year renewal contract with Penn State Health Morgans h...

    Wall Street falls, Nvidia soars BTC nears all-time highs Gold to move even further?   The ASX is poised to start flat on Tuesday, after overnight losses on Wall Street. At 8am AEDT, the ASX 200 index futures contract was pointing up...

Futures predict the ASX200 will trade mostly flat this morning, maybe down just a touch on open. US markets were down a little ahead of the next round of economic data. The Nasdaq dropped 0.4 per cent, the Dow Jones shed a quarter of...

ASX health sector lifts in line with broader markets as reporting season comes to end Morgans upgrades Polynovo as total revenue rises 65.6% on pcp to $48.8 million  Nanosonics cites hospital budgetary pressures as deferring purchasing dec...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AGI)) - Ainsworth Game Technology ((ART)) - Airtasker ((ALX)) - Atlas Arteria ((AFG)) - Australian Finance Group ((CAJ)) - Capitol Health ((CLU)) - Cluey ((DOC)) - Docto...

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.40% to 6,948.80. A poor session to kick off the new trading week with the ASX snubbing the strength in...

ASX health stocks rise in past five days in line with broader markets Mach7 Technologies reports record quarterly sales orders for Q1 FY24 Aroa maintains FY24 revenue growth forecast at 30% after strong Q2 Healthcare and life sciences exp...